T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Quaker Houghton
KWR
$2.96B
| $3.8M | ﹤0.01% |
27,637
-23,065
| -45% | -$3.11M |
|
1477
Preferred Bank
PFBC
$1.28B
| $3.79M | ﹤0.01% |
40,120
-40
| -0.1% | -$3.73K |
|
1478
NorthWestern Energy
NWE
$4.41B
| $3.79M | ﹤0.01% |
58,684
+1,640
| +3% | +$104K |
|
|
VISN
1479
Vistance Networks Inc
VISN
$2.64B
| $3.78M | ﹤0.01% |
208,573
-5,740
| -3% | -$99K |
|
1480
Ligand Pharmaceuticals
LGND
$5.73B
| $3.78M | ﹤0.01% |
19,992
+1,077
| +6% | +$207K |
|
1481
SentinelOne
S
$7.96B
| $3.77M | ﹤0.01% |
251,547
+22,158
| +10% | +$363K |
|
1482
Skywest
SKYW
$4.21B
| $3.77M | ﹤0.01% |
37,530
-486
| -1% | -$48.7K |
|
1483
U-Haul Holding Co Series N
UHAL.B
$12.7B
| $3.76M | ﹤0.01% |
80,483
+3,413
| +4% | +$166K |
|
1484
Plexus
PLXS
$7.16B
| $3.76M | ﹤0.01% |
25,554
+731
| +3% | +$107K |
|
|
AMTM
1485
Amentum Holdings
AMTM
$5.23B
| $3.76M | ﹤0.01% |
129,482
+11,307
| +10% | +$289K |
|
1486
Perimeter Solutions
PRM
$5.52B
| $3.74M | ﹤0.01% |
135,692
+1,753
| +1% | +$44.3K |
|
1487
WillScot Mobile Mini Holdings
WSC
$4.3B
| $3.73M | ﹤0.01% |
197,967
+17,976
| +10% | +$362K |
|
1488
RLI Corp
RLI
$5.87B
| $3.72M | ﹤0.01% |
58,107
+3,082
| +6% | +$194K |
|
1489
Palisade Bio
PALI
$362M
| $3.71M | ﹤0.01% |
+1,577,856
| New | +$3.03M |
|
|
BWIN
1490
Baldwin Insurance Group
BWIN
$2.94B
| $3.71M | ﹤0.01% |
154,126
+90,700
| +143% | +$2.31M |
|
1491
PJT Partners
PJT
$4.57B
| $3.69M | ﹤0.01% |
22,056
+831
| +4% | +$142K |
|
|
MRP
1492
Millrose Properties Inc
MRP
$5.01B
| $3.65M | ﹤0.01% |
122,318
+30,569
| +33% | +$959K |
|
1493
Independence Realty Trust
IRT
$4.02B
| $3.65M | ﹤0.01% |
208,610
+13,883
| +7% | +$230K |
|
1494
Graphic Packaging
GPK
$3.45B
| $3.64M | ﹤0.01% |
241,766
+16,272
| +7% | +$267K |
|
1495
American States Water
AWR
$3.52B
| $3.63M | ﹤0.01% |
50,145
+4,911
| +11% | +$361K |
|
1496
Varonis Systems
VRNS
$5.14B
| $3.63M | ﹤0.01% |
110,740
+10,847
| +11% | +$455K |
|
1497
Eastern Bankshares
EBC
$5.41B
| $3.63M | ﹤0.01% |
197,027
+22,553
| +13% | +$413K |
|
1498
MGE Energy Inc
MGEE
$3.07B
| $3.61M | ﹤0.01% |
46,055
+5,621
| +14% | +$462K |
|
1499
Otter Tail
OTTR
$3.9B
| $3.6M | ﹤0.01% |
44,543
+1,797
| +4% | +$146K |
|
|
ECG
1500
Everus Construction Group
ECG
$7.12B
| $3.58M | ﹤0.01% |
41,782
+2,021
| +5% | +$181K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.